These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 19298613
1. Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review. Jesse S, Steinacker P, Lehnert S, Gillardon F, Hengerer B, Otto M. CNS Neurosci Ther; 2009; 15(2):157-82. PubMed ID: 19298613 [Abstract] [Full Text] [Related]
4. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. Jabbari E, Holland N, Chelban V, Jones PS, Lamb R, Rawlinson C, Guo T, Costantini AA, Tan MMX, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Holton JL, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Williams NM, Grosset DG, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Woodside J, Houlden H, Rowe JB, Morris HR. JAMA Neurol; 2020 Mar 01; 77(3):377-387. PubMed ID: 31860007 [Abstract] [Full Text] [Related]
5. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage. Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguchi S, Deguchi K, Ikeda Y, Takao Y, Ohta T, Manabe Y, Sato S, Abe K. Intern Med; 2011 Mar 01; 50(22):2775-81. PubMed ID: 22082889 [Abstract] [Full Text] [Related]
6. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy. Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R. J Neural Transm (Vienna); 2016 Dec 01; 123(12):1435-1442. PubMed ID: 27334897 [Abstract] [Full Text] [Related]
7. Diagnostic value of blink reflex in multisystem atrophy, progressive supranuclear palsy and Parkinson disease. Szmidt-Salkowska E, Gawel M, Jamrozik Z, Salkowska-Wanat J, Gawel D, Kaminska A. Neurol Neurochir Pol; 2016 Dec 01; 50(5):336-41. PubMed ID: 27591058 [Abstract] [Full Text] [Related]
15. Lower urinary tract dysfunction in Parkinsonian syndromes. Vichayanrat E, Hentzen C, Batla A, Simeoni S, Iodice V, Panicker JN. Neurol Sci; 2021 Oct 01; 42(10):4045-4054. PubMed ID: 34318363 [Abstract] [Full Text] [Related]
16. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy. Suzuki M, Hashimoto M, Yoshioka M, Murakami M, Kawasaki K, Urashima M. BMC Neurol; 2011 Dec 22; 11():157. PubMed ID: 22192419 [Abstract] [Full Text] [Related]
17. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K, Bhatia K, Morris HR, Giunti P, Warner TT, de Silva R, Lees AJ, Zetterberg H. J Neurol Neurosurg Psychiatry; 2015 Nov 22; 86(11):1240-7. PubMed ID: 25589779 [Abstract] [Full Text] [Related]
18. [Differential diagnosis of parkinsonian syndromes using MRI]. Mahlknecht P, Schocke M, Seppi K. Nervenarzt; 2010 Oct 22; 81(10):1168-79. PubMed ID: 20857276 [Abstract] [Full Text] [Related]
19. Progressive Supranuclear Palsy, Corticobasal Degeneration, and Multiple System Atrophy. Greene P. Continuum (Minneap Minn); 2019 Aug 22; 25(4):919-935. PubMed ID: 31356287 [Abstract] [Full Text] [Related]
20. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN, NNIPPS Study Group. Brain; 2009 Jan 22; 132(Pt 1):156-71. PubMed ID: 19029129 [Abstract] [Full Text] [Related] Page: [Next] [New Search]